MINI PROSPECTUS - The Tax Shelter Report
MINI PROSPECTUS - The Tax Shelter Report
MINI PROSPECTUS - The Tax Shelter Report
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>MINI</strong> <strong>PROSPECTUS</strong><br />
WITH APPLICATION FORMS<br />
SPONSORED BY BREWIN DOLPHIN SECURITIES
This document, which comprises a mini prospectus (“Mini Prospectus”), contains information in summary form<br />
drawn from the Company’s Prospectus published on and dated 4 January 2005 (the “Prospectus”), which alone<br />
contains full details of the Company and the Shares. Terms defined in the Prospectus bear the same meaning when<br />
used in this document. <strong>The</strong> Directors are satisfied that this Mini Prospectus contains a fair summary of the key<br />
information set out in the Prospectus. <strong>The</strong> UK Listing Authority has authorised the issue of this document without<br />
the approval of its contents.<br />
In subscribing for Shares, you will be treated as subscribing solely on the basis of the Prospectus, which should be<br />
read in conjunction with this document and the Terms and Conditions of Application set out in this document and<br />
in the Prospectus.<br />
Application has been made for the Shares in the Company to be issued under the Offer to be admitted to the Official<br />
List of the UK Listing Authority and to trading on the London Stock Exchange’s market for listed securities. It is<br />
expected that such Admission will become effective, and that trading in the Ordinary Shares will commence, on<br />
7 February 2005, on the assumption that the minimum subscription under the Offer of £1 million is reached.<br />
Persons receiving this document should note that, in connection with the Offer, Brewin Dolphin Securities Ltd is<br />
acting for Eclipse VCT 2 plc and no-one else and will not be responsible to any other person for providing the<br />
protections afforded to customers of Brewin Dolphin Securities Ltd or providing advice in connection with the Offer.<br />
ECLIPSE VCT 2 plc<br />
(Incorporated and registered in England and Wales under the Companies Act 1985 with registered number 05260491)<br />
Offer for Subscription<br />
of up to 30,000,000 Ordinary Shares<br />
at an issue price of 100p per share payable in full on application<br />
Sponsor<br />
<strong>The</strong> Offer will be open from 8.00 a.m. on 5 January 2005 until the earlier of 3.00 p.m. on 30 June 2005 and the date<br />
on which the maximum subscription is reached. Dealings in respect of successful applications received on or before<br />
31 January 2005 will commence on 7 February 2005 (or earlier if the minimum subscription level of £1,000,000 is<br />
achieved before 31 January 2005). <strong>The</strong> Offer is not underwritten. <strong>The</strong> terms and conditions of the Offer are set out<br />
in Part 4 of this document, followed by an Application Form for use in connection with the Offer. <strong>The</strong> minimum<br />
subscription per investor is £3,000. Completed Application Forms in respect of the Offer should be sent by post or<br />
delivered by hand to Octopus Asset Management Limited, 14 Dover Street, London W1S 4LW.<br />
Your attention is drawn to the paragraph headed ‘Risk Factors’ set out on page 4 of this document.<br />
Copies of this document are available for inspection during normal business hours at the Document Viewing Facility<br />
at the Financial Services Authority, 25 <strong>The</strong> North Colonnade, London E14 5HS following the date of publication and<br />
may be obtained free of charge for the duration of the Offer, by collection from:<br />
Brewin Dolphin Securities Ltd<br />
5 Giltspur Street<br />
London EC1A 9BD<br />
Octopus Asset Management Ltd<br />
14 Dover Street<br />
London W1S 4LW<br />
Brewin Dolphin Securities Ltd<br />
34 Lisbon Street<br />
Leeds LS1 4LX<br />
1
Contents<br />
Page<br />
2 Offer Timetable<br />
2 Offer Statistics<br />
3 Key Information<br />
4 Risk Factors<br />
5 Letter from the Chairman<br />
Part 1<br />
6 About Eclipse VCT 2<br />
7 <strong>Tax</strong> Benefits for Investors<br />
7 Potential for High Returns<br />
8 Our Team<br />
10 Investment Process<br />
11 Management Remuneration<br />
12 <strong>The</strong> Offer<br />
12 Other Information<br />
Offer Timetable<br />
Offer opens 5 January 2005<br />
First allotment<br />
as soon as the minimum subscription of £1m is reached<br />
Dealings commence<br />
within 10 business days of allotment<br />
Share and tax certificates sent out<br />
within 15 business days of allotment<br />
Deadline for receipt of applications for final allotment in 2004/2005 tax year 5 April 2005<br />
Deadline for receipt of applications for final allotment in 2005/2006 tax year 30 June 2005<br />
<strong>The</strong> deadline for receipt of applications is subject to the Offer not being fully subscribed by an earlier date. <strong>The</strong> final<br />
closing date of the Offer may be extended by the Directors in their absolute discretion.<br />
Offer Statistics<br />
Offer Price per Ordinary Share<br />
100p<br />
Maximum number of Ordinary Shares in issue following the Offer 30,000,000<br />
Minimum number of Ordinary Shares in issue following the Offer 1,000,000<br />
Initial Net Asset Value per Ordinary Share 95p*<br />
Commission available to introducers:<br />
Initial<br />
2.25% of gross proceeds<br />
Plus<br />
Annual (subject to an aggregate maximum of 4.5% of initial net asset value per Share) 0.375% of net asset value<br />
* Based on a 100p subscription price less expenses of the Offer of 5p per Ordinary Share<br />
Page<br />
15 Directors and Advisers<br />
16 Definitions<br />
Part 2<br />
17 <strong>Tax</strong>ation Considerations for Investors<br />
Part 3<br />
19 Conditions to be met by Venture Capital Trusts<br />
Part 4<br />
21 Terms and Conditions of Application<br />
Application Procedure<br />
Application Forms<br />
2
Key Information<br />
Why Invest in a VCT?<br />
VCTs offer two main advantages over other investment<br />
products in the market. Firstly, the structure of a VCT<br />
provides investors with a combination of tax<br />
advantages unmatched by any other kind of<br />
investment product in the UK. Secondly, VCTs offer<br />
investors the opportunity to benefit from the higher<br />
returns that can be achieved by investing in UK<br />
smaller companies.<br />
Background<br />
VCTs were introduced by the UK Government in 1995<br />
to encourage individuals to invest in the UK’s fastest<br />
growing and potentially highest return companies.<br />
<strong>The</strong> Government achieved this by offering investors an<br />
up-front income tax relief of 20% of the amount<br />
invested. As a result, more than £1.6 billion has been<br />
invested in VCTs between 1995 and 2004. (Source:<br />
Allenbridge)<br />
<strong>Tax</strong> Law Changes<br />
<strong>The</strong> Finance Act 2004 introduced changes to VCT<br />
legislation. <strong>The</strong>se were designed to make VCTs even<br />
more attractive to investors in order to increase the<br />
amount of money being invested into some of the UK’s<br />
most exciting young companies. <strong>The</strong> main change is<br />
an increase in the level of up-front income tax relief<br />
from 20% to 40%.<br />
At present, the legislation states that this increased<br />
relief will only be available for a period of two years<br />
from 6 April 2004.<br />
Effect on Investors<br />
<strong>The</strong> tax changes mean that if you invest £10,000 in<br />
Eclipse 2, your income tax bill will be reduced by<br />
£4,000 (provided that the Shares are held for at least<br />
three years) - i.e. your investment of £10,000<br />
effectively only costs you £6,000.<br />
In addition to these benefits, all capital gains on sale<br />
of Shares and all dividend payments will be tax-free.<br />
Why Invest in Eclipse VCT 2?<br />
Eclipse 2 also offers individual investors the<br />
opportunity to enjoy the potentially high returns of the<br />
UK venture capital market. This market has<br />
consistently provided investors with superior<br />
long-term returns compared to investing in large<br />
quoted companies. In the ten years to December<br />
2003, the average total return (net of fees) to<br />
investors in UK venture capital funds was 14.2% per<br />
annum. This compares to the FTSE 100 return of<br />
6.1% per annum. (Source: PwC & BVCA Performance<br />
Measurement Survey 2003).<br />
<strong>The</strong> decision to launch Eclipse 2 so soon after the<br />
closing of Eclipse VCT, which was the most successful<br />
VCT launch in 2004 (by funds raised), was the result of<br />
the number and the quality of the investment<br />
opportunities the Manager is currently seeing.<br />
Additionally, Eclipse 2 will be able to co-invest<br />
alongside the Manager’s other VCTs, allowing the Fund<br />
to invest in larger deals and, therefore, also<br />
later-stage companies.<br />
Our Team<br />
<strong>The</strong> Manager has built a team with substantial<br />
experience and a strong track record in small company<br />
investing to help ensure the best possible returns for<br />
investors. Members of the Investment Committee<br />
have over 50 years of experience in successfully<br />
sourcing, making and exiting investments. <strong>The</strong>ir<br />
individual track records are outstanding and specific<br />
details are included on page 9.<br />
Eclipse 2 will also benefit from the research<br />
conducted by the other fund managers and analysts at<br />
Octopus, in particular the team working on the<br />
Phoenix VCT. Phoenix has made 25 investments since<br />
launch and its investments have increased in value by<br />
an average of 31.9% (as at 17 December 2004).<br />
Eclipse 2’s AIM investments will be made under the<br />
same investment policy as Phoenix.<br />
Award Winning Manager<br />
Octopus’ last VCT launch – Eclipse VCT – was voted<br />
“New Venture Capital Fund of the Year 2004” in the<br />
Investor AllStar Awards. <strong>The</strong> award, voted for by fund<br />
managers within the venture capital industry, was<br />
based on the Fund’s innovative investment strategy<br />
and the active nature of Octopus’ investment<br />
professionals.<br />
How to Invest<br />
An application form is attached at the end of this<br />
document. <strong>The</strong> minimum investment is £3,000.<br />
Although there is no maximum size of investment, tax<br />
reliefs are available on a maximum investment of<br />
£200,000 per individual in any one tax year.<br />
Listing<br />
Once the Fund has reached its minimum subscription<br />
of £1 million, its Ordinary Shares will be admitted to<br />
the Official List of the UK Listing Authority and to<br />
trading on the London Stock Exchange. <strong>The</strong> maximum<br />
subscription is £30 million.<br />
<strong>The</strong> above information should be read in conjunction with the full text of this document, from which it is derived.<br />
Investors should read the whole document and not just rely on the key information set out above. Information on<br />
tax reliefs above relates to Qualifying Subscribers who hold the Shares for at least three years. Potential Investors<br />
should seek their own independent tax advice.<br />
3
Risk Factors<br />
Prospective investors should be aware that the value of Ordinary Shares may go down as well as up, in which case<br />
an investor may not get back the amount originally invested. <strong>The</strong> price at which the Ordinary Shares are traded<br />
may not reflect the net asset value of the Fund. Investment in Eclipse 2 should be viewed as a longer-term<br />
investment. <strong>The</strong> attention of prospective investors is drawn to the following risk factors:<br />
• Past performance is no indication of future performance.<br />
• <strong>The</strong>re can be no assurances that the Company will meet its objectives or that suitable investment opportunities<br />
will be identified.<br />
• An investment in a VCT may not be suitable for all investors. If investors have any doubts they should seek<br />
advice from their independent financial adviser.<br />
• Investments made by the Fund will be in companies whose shares are not readily marketable and therefore may<br />
be difficult to realise. <strong>The</strong> fact that a share is traded on AIM or OFEX does not guarantee its liquidity. <strong>The</strong> spread<br />
between the buying and selling price of such companies’ shares may be wide and thus the mid-market price<br />
used for valuation may not be achievable in the event of sale.<br />
• Whilst it is the intention of the Directors that the Fund will be managed so as to qualify as a VCT, there can be<br />
no guarantee that it will qualify or that such status will be maintained. A failure to meet the qualifying<br />
requirements could result in the Fund losing the tax reliefs previously or prospectively obtained, resulting in<br />
adverse tax consequences for investors, including a requirement to repay the 40% income tax relief.<br />
• It is possible for investors to lose their tax reliefs by themselves taking or not taking certain steps, and investors<br />
are advised to take their own independent financial advice on the tax aspects of their investment.<br />
• Levels and bases of, and relief from, taxation are subject to change. Such changes could be retrospective.<br />
• Although the Fund will be admitted to the Official List of the UK Listing Authority and to trading on the London<br />
Stock Exchange’s market for listed securities, there will most likely be an illiquid market and investors may find<br />
it difficult to realise their investment during the early years of the life of the Fund.<br />
• <strong>The</strong> Company is seeking up to £30 million in the Offer. To the extent that a relatively small level of funds is raised<br />
the Company may not be able to diversify its portfolio sufficiently.<br />
• <strong>The</strong> Fund will invest in companies with gross assets of not more than £15 million prior to investment.<br />
Such companies generally have a higher risk profile than larger “blue chip” companies.<br />
• Any realised losses on disposal of shares in a VCT cannot be used to create an allowable loss for capital gains<br />
tax purposes.<br />
• Companies in which a VCT makes an investment may include companies undergoing significant change.<br />
Such businesses are usually exposed to greater risks than established businesses.<br />
4
Letter from the Chairman of<br />
Eclipse VCT 2 plc<br />
Eclipse VCT 2 PLC<br />
14 Dover Street<br />
London<br />
W1S 4LW<br />
4 January 2005<br />
Dear Investor<br />
I’m delighted to be writing to you as Chairman of Eclipse VCT 2.<br />
I believe that this is one of the most attractive investment opportunities currently available. It enables you to<br />
take advantage of the new VCT tax changes, as well as Octopus’ expertise in smaller company stock selection.<br />
<strong>Tax</strong> Changes<br />
In the March 2004 Budget, the Chancellor announced important changes to the legislation governing<br />
investments into VCTs. <strong>The</strong> biggest change was to increase the level of up-front income tax relief to investors<br />
from 20% to 40% for a period of two years until April 2006. This makes VCTs one of the most tax efficient<br />
investments available to UK individuals.<br />
Award Winning Manager<br />
As well as significant tax advantages, an investment in Eclipse 2 provides you with the potential for superior<br />
returns offered by the UK’s best performing asset class. Octopus’ commitment and success within the VCT<br />
market was recognised when its peers voted its last VCT launch “New Venture Capital Fund of the Year” in the<br />
Investor AllStar Awards. Eclipse was the most successful VCT launch last year in terms of funds raised, raising<br />
almost £30 million from around 2,500 investors.<br />
Personal Service<br />
If you do decide to invest, you’ll see that the Team prides itself not only on its strong track record but also on<br />
meeting the needs of each individual investor. That’s why you’ll be kept as involved and informed throughout<br />
the investment process as you want to be. If you want to receive an update every time we make an investment,<br />
you will.<br />
I look forward to welcoming you as a shareholder.<br />
Yours sincerely<br />
Marc Vlessing<br />
Chairman<br />
5
Part 1<br />
About Eclipse VCT 2<br />
Eclipse 2 is a new VCT that will invest in a diversified portfolio of unlisted (including AIM quoted) UK companies with<br />
the intention of maximising tax-free capital and income returns for its investors.<br />
VCTs offer two main advantages over other investment products in the market. Firstly, the structure of a VCT<br />
provides investors with a combination of tax advantages unmatched by any other investment product in the UK.<br />
Secondly, VCTs offer investors the opportunity to benefit from the higher returns that can be achieved by<br />
investing in UK smaller companies. Regarding Eclipse VCT 2, the Directors believe that this opportunity is further<br />
enhanced by current low valuations and by the quality of the Team that has been assembled to manage the Fund.<br />
I. <strong>Tax</strong> Benefits for Investors<br />
One of the reasons that VCTs have proved so popular is that, provided individuals hold the shares for three<br />
years, they offer an up-front tax relief which represents a significant return on any money invested. In<br />
addition to this benefit, all capital gains on sale of Shares and all dividend payments will be tax-free (see<br />
section entitled “<strong>Tax</strong> Benefits for Investors” on page 7).<br />
II. High Returns<br />
Investing in venture capital backed companies has consistently produced superior returns to investing in the<br />
broader equity market. Eclipse 2 is a way for individuals to access what has historically been the UK’s best<br />
performing asset class.<br />
<strong>The</strong> decision to launch Eclipse 2 so soon after the launch of Eclipse VCT, which was the most successful VCT<br />
launch in 2004 (by funds raised), was the result of the number and the quality of the investment<br />
opportunities the Manager is currently seeing. Additionally, Eclipse 2 will be able to co-invest alongside the<br />
Manager’s other VCTs, allowing the Fund to invest in larger deals and, therefore, later-stage companies.<br />
We have built a team with substantial experience and a strong track record to ensure that we achieve the<br />
best possible returns for investors. Members of the Investment Committee have over 50 years of experience<br />
in successfully sourcing, making and exiting investments. <strong>The</strong>ir individual track records are outstanding and<br />
specific details are included on page 9.<br />
In relation to your investment in Eclipse 2, the Team prides itself not only on the strong track record of the<br />
Investment Manager but also on meeting the needs of each individual investor. <strong>The</strong> Board and the<br />
Investment Manager aim to provide a personalised and educational approach to investment. As well as<br />
receiving regular investment updates, investors will be invited to the regional investment seminars and<br />
workshops that will be held. Investors are also encouraged to speak directly to the fund managers who are<br />
investing their money.<br />
6
<strong>Tax</strong> Benefits for Investors<br />
<strong>The</strong> Finance Act 2004 has made changes to the VCT legislation. <strong>The</strong>se changes are designed to make VCTs even<br />
more attractive to investors and thereby increase the amount of money being invested into some of the UK’s most<br />
exciting young companies. <strong>The</strong> main change has been to increase the level of up-front income tax relief from 20%<br />
to 40%. <strong>The</strong> legislation states that this increased up-front relief will only be available on new investments in VCTs<br />
for a period of two years from 6 April 2004.<br />
To summarise, individual investors in Eclipse 2 are entitled to the following benefits:<br />
• up-front income tax relief to the investor of 40% on amounts invested between £3,000 and £200,000 (provided<br />
that the shares are held for at least three years);<br />
• dividends paid to investors are free of income tax; and<br />
• capital gains made by investors on disposal of Shares are tax-free.<br />
<strong>The</strong> following shows the effect of the increased tax reliefs for an individual who invests £10,000 in Eclipse 2:<br />
Initial Investment £10,000<br />
Less income tax relief £4,000<br />
Effective cost to investor £6,000<br />
i.e. your investment of £10,000 effectively only costs you £6,000.<br />
Investors should obtain their own independent financial advice on their eligibility for tax relief. A general guide to<br />
the conditions to be met in order for the tax reliefs to be available is given in Parts 2 and 3 of this Document.<br />
<strong>The</strong> above information should be read in conjunction with the full text of this document, from which it is derived.<br />
Investors should read the whole document and not just rely on the summarised information set out above.<br />
Potential for High Returns<br />
Background<br />
Eclipse 2 offers individuals the opportunity to enjoy the potentially higher returns of the UK venture capital market.<br />
This market has consistently provided investors with superior long-term returns compared to investing in large<br />
quoted companies. In the five and ten year periods to December 2003, the average total return (net of fees) to<br />
investors in UK venture capital funds was 10.2% and 14.2% per annum respectively. This compares to the FTSE 100<br />
return of –1.1% and 6.1% per annum over the same time periods.<br />
FTSE 100 vs Venture Capital Long-Term Returns*<br />
5 years to December 2003 (%) 10 years to December 2003 (%)<br />
FTSE 100 -1.1% 6.1%<br />
UK Venture Capital 10.2% 14.2%<br />
Relative Outperformance 11.3% 8.1%<br />
Source: PwC and BVCA Performance Measurement Survey 2003<br />
* Past performance is no guarantee of future performance.<br />
7
Unlike some VCTs, Eclipse 2 will not be investing in start-up or seed stage companies as the Directors believe that<br />
the risks are too high and that the expected time to exit is too long for many investors. Instead, we believe that the<br />
ideal time to invest in companies is when they have proven their business models and are looking for<br />
expansion capital.<br />
<strong>The</strong> Current Opportunity<br />
<strong>The</strong> Directors believe that there has been a lack of money available to be invested into UK smaller companies over<br />
the last four years. This has delayed some companies’ plans for expansion and has caused valuation levels of most<br />
private businesses to fall over this period.<br />
<strong>The</strong> Government’s desire to address this situation is reflected in its decision to increase the level of up-front income<br />
tax relief to investors in VCTs. We believe that the effect of this is already starting to come through.<br />
We are encouraged by both the number and the quality of the investment opportunities that we are currently<br />
seeing. A further advantage is that Octopus already manages three VCTs, and Eclipse 2 should be able to co–invest<br />
alongside the other VCTs in larger and later-stage investment opportunities.<br />
<strong>The</strong> Directors’ view is that the Company’s prospects for the current financial year are good.<br />
Our Team<br />
Our team comprises the Board of Directors and the Investment Committee. <strong>The</strong> Board consists of three directors,<br />
two of whom are independent of Octopus. <strong>The</strong> Board has overall responsibility for the Fund and its investment<br />
policies and has appointed Octopus as the Investment Manager. Octopus will be represented by the five members<br />
of the Investment Committee.<br />
<strong>The</strong> Board<br />
Marc Vlessing (Non-Executive Chairman – Age 42)<br />
Marc started his career as a corporate financier with County NatWest. Upon leaving County NatWest in 1991, he set<br />
up Media Finance, a management consultancy business specialising in the media sector. In 1997, Marc was<br />
appointed Chief Executive of Crescent Entertainment which comprised a large group of West End theatres, a number<br />
of cinemas and some film and TV businesses. Marc built up the group and assisted in its successful sale in 2000.<br />
He then became Chief Executive of First Call International, the UK's largest independent ticketing business. More<br />
recently, Marc has become a principal and main investor in S1 Homes, a developer of affordable housing. Marc sits<br />
on the Board of ProVen Media VCT and has extensive venture capital experience, both as an entrepreneur and as an<br />
investor.<br />
Matt Cooper (Non-Executive Director – Age 38)<br />
Matt is the Chairman of Octopus Asset Management Limited, the Investment Manager of Eclipse VCT 2. Prior to<br />
joining Octopus, Matt was the Principal Managing Director of Capital One (Bank) Europe plc where he was<br />
responsible for all aspects of the company’s strategic direction and day-to-day operations in Europe. He led the UK<br />
portion of the business from start-up to two million customers, generating revenues of over £275 million and<br />
employing over 2,000 people.<br />
David Lambert (Non-Executive Director – Age 49)<br />
David has over 17 years’ experience of private equity investment in smaller middle market UK companies. David<br />
was formerly Managing Director of Royal Bank Development Capital which comprised six offices across the UK<br />
focusing on private equity investments up to £10 million. He was responsible for developing this business from its<br />
original inception in 1996 as the NatWest Pioneer Fund, commencing with a single office in Nottingham and an<br />
initial focus on investments up to £1 million. Prior to this he was a Director with NatWest Equity Partners, where he<br />
worked with the lead fund manager of Eclipse VCT, Chris Allner. He is currently a Director of Alcuin Capital Ltd, a<br />
private equity fund manager.<br />
David is a chartered accountant, having trained with Price Waterhouse in Birmingham and is a graduate of Bristol<br />
University with a BSc in Economics and Accounting.<br />
8
<strong>The</strong> Investment Committee<br />
<strong>The</strong> Investment Committee is made up of five fund managers with more than 50 years of combined investment<br />
experience. This team includes highly experienced venture capital managers, who have strong track records of<br />
sourcing, making and realising unquoted and AIM listed investments with significant capital gains. <strong>The</strong>y have<br />
demonstrated this ability in a range of different stock market conditions.<br />
Chris Allner<br />
Chris has over two decades of venture capital experience at some of Europe’s leading venture capital houses and<br />
has an excellent track record of generating consistent returns for his investors. In the period 1990-2003, Chris was<br />
directly responsible for more than 30 deals, achieving an average annual rate of return of more than 35% for his<br />
investors.<br />
Chris started his career at 3i in 1982 before joining Charterhouse Development Capital in 1987. He moved to<br />
NatWest Equity Partners in 1989, becoming the director responsible for the Southern regional office. In 2001, Chris<br />
became a director of ProVen Private Equity, manager of both of the Proven VCTs and other venture capital funds.<br />
Chris graduated from Oxford University with an MA in Politics, Philosophy and Economics and holds a Certified<br />
Diploma in Accounting and Finance.<br />
Joseph Bergin<br />
Joseph has extensive investment experience from having worked for ten years for 3i (one of Europe’s largest<br />
venture capital companies) in both the UK and Continental Europe. He has led on a number of different transactions<br />
including Management Buyouts, Development Capital, and Public to Private. His sector experience includes<br />
healthcare, food and technology. Joseph has achieved an average return of over 25% per annum on his realised UK<br />
investments in the period to December 2003.<br />
Joseph recently completed the Sloan Masters programme (an MBA and MSc in Management) at London<br />
Business School.<br />
Andrew Cavaghan<br />
Prior to joining Octopus, Andrew set up and managed a generalist venture capital fund on behalf of GLE. While at<br />
the company, Andrew had primary responsibility for deal origination but also represented GLE at Board level on a<br />
number of portfolio companies. In 2003, Andrew was nominated as one of the "Top Ten Young Venture Capitalists<br />
to Watch" in the Investor AllStar Awards.<br />
Andrew graduated with a BA in Philosophy from University College London. He also has a postgraduate diploma in<br />
Law from the York College of Law and is a qualified barrister.<br />
Guy Myles<br />
Guy is the Head of Investment at Octopus Asset Management. Prior to joining Octopus, Guy worked at Mercury<br />
Asset Management, one of Europe’s leading fund management companies. Guy’s most recent position at Mercury<br />
was as one of the fund managers on the global equity team, where he was also head of the technology research<br />
team.<br />
Guy also sits on the Investment Committee of the Phoenix VCT plc, which Octopus launched in 2002. This fund<br />
accounted for around 20% of all VCT funds raised in the 2002/03 tax year and has made 25 investments since<br />
launch. <strong>The</strong> average investment has increased in value by 31.9% (as at 17 December 2004).<br />
Guy graduated with a BSc from Bristol University.<br />
Richard Power<br />
Richard has nine years experience managing UK smaller company funds, most recently at Close Brothers. Prior to<br />
that, Richard spent five years at Duncan Lawrie Ltd. Whilst Richard was managing the Duncan Lawrie Smaller<br />
Companies Fund, it won a number of awards and was the best performing UK smaller companies fund over the one,<br />
three and five years ending 31st December 1999. Richard also sits on the Investment Committee of the Phoenix VCT<br />
plc and will only focus on identifying AIM investment opportunities for Eclipse 2.<br />
Richard graduated from Exeter University with a BA (Hons) in Economic and Political Development.<br />
<strong>The</strong> Directors and the Investment Committee are investing £80,000 in the Offer.<br />
9
Investment Process<br />
Eclipse 2’s investment strategy aims to deliver absolute returns on its investments rather than a performance<br />
measured against the market indices. This strategy aims to provide investors with attractive returns in all market<br />
conditions whilst striving to minimize the amount of risk.<br />
1. What kind of companies do we invest in?<br />
Eclipse 2 will provide individuals with a diversified portfolio of investments in unlisted UK smaller<br />
companies. <strong>The</strong> split of this portfolio will be as follows:<br />
• approximately 80% will be invested in companies operating in sectors which the team believes have<br />
excellent growth prospects and where the companies have demonstrated a clear and sustainable<br />
advantage over their competition. This will include unlisted and, potentially, AIM or OFEX traded<br />
businesses. As well as typically occupying strong market niches, the companies we invest in will have<br />
proven management teams with a clear record of success in growing a company’s business, including<br />
growth via acquisition.<br />
• approximately 20% will remain in cash to facilitate share buybacks (further details in relation to the<br />
buyback policy can be found on page 13 of this document).<br />
Individual investments are expected to range in size from £200,000 to £1 million depending on the stage of<br />
development of the company and the anticipated need for future funding. Initial investments may be<br />
increased as a result of follow-on fundings.<br />
<strong>The</strong>se investments will be spread across a broad range of sectors in the UK to create a diversified portfolio.<br />
We expect the portfolio to be spread across 20 to 30 investments and the total amount invested into any one<br />
sector and any one company will be limited to a maximum of 20% and 10% of the Fund respectively.<br />
2. How do we find these companies?<br />
Our Team has an established network for generating deal flow for the Fund. In building this network there<br />
has been a focus on individuals with a track record of successfully developing businesses of the type<br />
targeted by the Fund. Such people provide invaluable industry insight in helping us to pre-screen potential<br />
investment opportunities.<br />
3. How will we make the decision to invest?<br />
Prior to investment, the proceeds of the Offer will be held in cash, earning interest on behalf of investors.<br />
Unlike many fund managers, we do not measure our performance relative to a stock market index. If we do<br />
not believe that a particular investment can make a significantly better return than we could by leaving<br />
investors’ money in the bank, then we will not invest.<br />
We are aware of the requirement to be 70% invested in Qualifying Holdings by 31 January 2008 , and have<br />
retained Grant Thornton UK LLP, one of the UK’s leading firms of accountants, to advise on the maintenance<br />
of the VCT status.<br />
Before investing in a company, the Team members will conduct their own fundamental analysis. To<br />
understand and evaluate the business risks, the Team goes through a rigorous process that involves<br />
spending time with a company’s management team, their customers and suppliers, evaluating competitors<br />
and building and reviewing financial models.<br />
In addition to undertaking financial and legal due diligence, we will introduce industry relevant people or<br />
other professionals to provide additional market commentary and an independent assessment of the<br />
company’s business model and its management.<br />
Investment proposals recommended by the Investment Managers will be formally reviewed by the Directors<br />
at their regular Board meetings.<br />
10<br />
4. How will we manage our investments?<br />
<strong>The</strong> process does not end with our decision to invest. We will constantly re-evaluate our portfolio and<br />
monitor every investment to ensure that it performs to our expectations. We will also seek to add value to<br />
investee companies through strategic and financial input, helping with the hiring of key staff, advising on<br />
potential acquisitions and, ultimately, helping to prepare the company for a trade sale or stock market<br />
listing. In many cases, we will take a seat on the board of these companies.
5. What is the expected return?<br />
<strong>The</strong> information contained below is not intended to be a dividend or profit forecast.<br />
<strong>The</strong> Directors are confident that Eclipse has assembled a team which is well placed to generate strong<br />
returns for its investors and the Board has confidence in the proposals for the current financial year.<br />
In the short-term, provided the relevant conditions are met, you will receive:<br />
• up-front income tax relief equivalent to 40% of the money that you invest. This means that if you invest<br />
£10,000, your income tax bill for that tax year will be reduced by £4,000;<br />
• following the publication of each year’s <strong>Report</strong> and Accounts, the Board intends to adopt a dividend<br />
policy whereby any interest and dividends received in any year, less the costs of running the VCT, will be<br />
paid out to shareholders by way of dividend. <strong>The</strong> Directors expect that the first dividend will be paid in<br />
June 2006. Investors should realise that this dividend will depend on the size of the Fund and the<br />
interest rates available for cash held on deposit by the Fund.<br />
In the longer-term (from year three onwards) returns to investors will come from the underlying capital<br />
growth of the portfolio of investments as well as dividends and income received from these investments.<br />
From the income received and the capital gains realised, we intend to pay out a series of tax-free dividends<br />
to investors. We will aim to make this dividend stream consistent year-on-year.<br />
Management Remuneration<br />
Management Fees<br />
Octopus Asset Management has been appointed as the Investment Manager of the Fund. <strong>The</strong> agreement is for an<br />
initial period of 5 years from Admission, and may be terminated by either party on 12 months' notice expiring at the<br />
end of the fixed term or at any time thereafter.<br />
<strong>The</strong> Investment Manager will receive:<br />
(a) an annual management fee of 2.0% of net assets (exclusive of VAT and payable quarterly in advance);<br />
(b) an accounting and administration fee of 0.3% of net assets (exclusive of VAT); and<br />
(c) a performance fee which is outlined in more detail below.<br />
Assuming full subscription, annual running costs are estimated to be no more than 2.7% of net assets. <strong>The</strong> running<br />
costs of the Fund will include the management fees described above (excluding the performance fee), accounting<br />
and administration fees, Directors’ fees, audit, taxation advice, sponsor’s and registrar’s fees and the costs of<br />
communicating with Shareholders. Total annual running costs will be capped at 3.5% of net assets (excluding<br />
irrecoverable VAT).<br />
<strong>The</strong> Investment Manager retains the right to charge up-front arrangement and syndication fees to the companies in<br />
which the Fund invests. Such charges are in line with industry practice and will not exceed 3% of the cost of each<br />
investment plus VAT (if applicable). <strong>The</strong> costs of all deals that do not proceed to completion will be borne by the<br />
Investment Manager and not by the Fund. <strong>The</strong> Investment Manager may also receive ongoing director’s fees and<br />
monitoring fees from the investee companies as appropriate and in line with market practice.<br />
Performance Related Incentive Fee<br />
In line with industry practice, the Investment Manager will be entitled to performance related incentive fees.<br />
<strong>The</strong> incentive fees are designed to encourage significant dividend payments to Shareholders as well as strong<br />
performance in terms of capital and income growth, before any performance related incentive fee payment is<br />
made. <strong>The</strong>refore, if by the end of a financial year (commencing no earlier than close of the 2007/2008 financial<br />
year), declared distributions per Share have reached 40p in the aggregate and if the Performance Value at that date<br />
exceeds 130p per Share, the Investment Manager will be entitled to an incentive fee equal to 20% of the excess of<br />
such Performance Value over 100p per Share. If, on a subsequent financial year end, the Performance Value of the<br />
Fund falls short of the Performance Value on the previous financial year end, no incentive fee will arise. If, on a<br />
subsequent financial year end, the Performance Value exceeds the previous best Performance Value of the Fund,<br />
the Investment Manager will be entitled to 20% of such excess.<br />
11
<strong>The</strong> Offer<br />
Details of the Offer for Subscription<br />
It is proposed to allot pursuant to the Offer between 1 million and 30 million Ordinary Shares. <strong>The</strong> Ordinary Shares<br />
will be offered at 100p per Share payable in full, by cheque or banker’s draft, on application.<br />
<strong>The</strong> Offer will be open from 5 January 2005 until the earlier of 3.00 p.m. on 30 June 2005 and the date on which the<br />
maximum subscription is reached (or until such time as the Company and Brewin Dolphin Securities agree).<br />
<strong>The</strong> terms and conditions of the Offer are set out in Part 4 of this document and an Application Form, together with<br />
details of the application procedure, is set out at the end of this document.<br />
Application has been made to the UK Listing Authority for the Ordinary Shares issued pursuant to the Offer to be<br />
admitted to the Official List. Application has also been made to the London Stock Exchange for admission to trading<br />
on the London Stock Exchange’s market for listed securities. <strong>The</strong> Ordinary Shares will be issued in registered form.<br />
It is intended that an initial allotment of Ordinary Shares will be made as soon as the minimum subscription of £1<br />
million is reached. Dealings in the shares are expected to commence on 7 February 2005, subject to the<br />
minimum subscription of £1 million being achieved by that date.<br />
In the event that the Offer is oversubscribed, allotment will be made to investors on a first come first served basis.<br />
Launch Costs<br />
<strong>The</strong> expenses of the Offer will be guaranteed by Octopus to amount to 5p per Share such that the initial net assets<br />
of the Fund will be equal to 95p per Share. Whatever the level of subscription reached, the total launch cost will<br />
amount to 5% of total funds subscribed. Octopus will be responsible for paying all of the costs of the Offer<br />
including listing expenses and any initial intermediary commissions.<br />
Intermediary Commission<br />
Authorised financial intermediaries will be entitled to receive an initial commission at the rate of 2.25% on the<br />
amount invested by their clients. Additionally, provided that the intermediary continues to act for the client and the<br />
client continues to hold Ordinary Shares, intermediaries will be paid an annual trail commission of 0.375% of the<br />
amount invested.<br />
No payment of trail commission shall be made to the extent that the cumulative trail commission would exceed<br />
4.5% of the initial net asset value per Share.<br />
Authorised financial intermediaries may agree to waive part or all of their initial commissions. In such<br />
circumstances, an investor’s application will attract an additional allotment of Ordinary Shares at no greater cost to<br />
the Company or the investor and the commission waived will be used to satisfy the subscription price of such<br />
Shares.<br />
Minimum and Maximum Investment<br />
<strong>The</strong> minimum subscription level under the Offer will be £3,000. Applications in excess of £3,000 may be made for<br />
any higher amount in multiples of £1,000, subject to availability. <strong>The</strong>re is no maximum investment but the<br />
maximum investment on which income tax relief can be claimed is £200,000 in any Income <strong>Tax</strong> Year. Husbands and<br />
wives may apply separately for up to £200,000 each.<br />
Other Information<br />
Dividend Policy<br />
<strong>The</strong> information contained below is not intended to be a dividend or profit forecast.<br />
Eclipse 2 will initially be structured as an investment company to take advantage of its ability to pay out tax-free<br />
dividends to its investors. While it is an investment company it may only distribute income. <strong>The</strong> Directors intend to<br />
dispense with this status once sufficient capital profits are realised for distribution as dividends.<br />
12
As an indication, in the first two years, the Directors expect to pay a final dividend each year, the first dividend being<br />
in respect of the financial period ending 31 January 2006, which is expected to be declared in April 2006. <strong>The</strong><br />
dividends payable for the periods ending 31 January 2007 and 31 January 2008 are expected to be paid out of<br />
interest earned from money market deposits and from dividends received from investee companies.<br />
<strong>The</strong> amount of these dividends depends, amongst other things, on the amount of funds received in the Offer, the<br />
time at which these funds are received, the rate of investment by the Company, and the level of interest rates. No<br />
commitment is made as to the level of the dividend but the Board will look to pay out as much of the Company’s<br />
distributable reserves as it is able in dividends in each of the first two financial years.<br />
VCT Status Monitoring<br />
<strong>The</strong> Fund has retained Grant Thornton UK LLP to advise on tax matters generally and, in particular, the maintenance<br />
of VCT status. <strong>The</strong> Inland Revenue has given provisional approval of the Fund as a Venture Capital Trust. Final<br />
approval will be sought as soon as possible, and in any event no later than the accounting period of the VCT<br />
beginning three years after provisional approval. Grant Thornton UK LLP will assist the Investment Manager in<br />
establishing the status of investments as Qualifying Holdings and monitoring progress towards achieving full VCT<br />
approval, but will report directly to the Board.<br />
Whilst it is the intention of the Directors that the Fund will be managed so as to qualify as a VCT, there can be no<br />
guarantee that it will qualify or that such status will be maintained. A failure to meet the qualifying requirements<br />
could result in the Fund losing the tax reliefs previously obtained, resulting in adverse tax consequences for<br />
investors, including a requirement to repay the 40% income tax relief.<br />
Life of the Fund<br />
It is intended that the Fund should have an unlimited life, but Shareholders will have the opportunity to review the<br />
future of the Fund at appropriate intervals. <strong>The</strong>refore, the Articles of Association of the Company require the<br />
Directors to put a proposal for the continuation of the Company to Shareholders at the 10th annual general meeting<br />
of the Company (the “10th AGM”), and, if passed, every fifth anniversary thereafter.<br />
Realisation of Ordinary Shares<br />
<strong>The</strong> Shares will be traded on the London Stock Exchange after Admission and thereby Shareholders may sell their<br />
Ordinary Shares at any time to realise their investment. Investors should be aware that dealings in the Ordinary<br />
Shares of the Fund are likely to be relatively illiquid. Shareholders must hold their Ordinary Shares for at least 3<br />
years to retain the income tax relief described elsewhere in this document.<br />
Buyback Facility<br />
<strong>The</strong> Directors are aware of the possibility of the Ordinary Shares trading at a discount to net asset value. <strong>The</strong><br />
Directors consider that the Fund should have the ability, subject to having sufficient distributable reserves, to<br />
purchase its Ordinary Shares in the market with the aim of reducing this discount and providing an opportunity for<br />
Shareholders who wish to sell, given the likely illiquidity referred to above. It is intended that such purchases would<br />
happen at less than or equal to a 10% discount to net asset value.<br />
Any decision by the Board to submit to Shareholders a proposal for the Company to be authorised to purchase its<br />
own equity shares other than the renewal of an existing authority will be subject to the Listing Rules.<br />
Future Allotments<br />
<strong>The</strong> Company is seeking to raise £30 million in the Offer.<br />
13
Co-Investment Policy<br />
Octopus Asset Management currently manages three other VCTs. <strong>The</strong> Directors believe that this provides investors<br />
in Eclipse VCT 2 with a number of advantages, particularly in relation to deal flow and the ability for Eclipse VCT 2<br />
to invest in larger deals and, therefore, later-stage companies<br />
Allocations of investment opportunities between VCTs managed by Octopus are generally made pro-rata to the<br />
initial level of demand by each fund rather than by each fund’s respective size.<br />
In the case of Eclipse VCT and Eclipse 2, co–investment will be made pro-rata to the fund size in accordance with the<br />
investment management agreement dated 21 December 2004 made between the Company and the Investment<br />
Manager. To the extent that it differs from this, an alternative split will require the approval of the independent Directors.<br />
In the event of a conflict of interest on the part of the Manager (including where an investment is proposed in a<br />
company in which one of the existing VCTs has an investment), such an investment will require the approval of the<br />
independent Directors.<br />
14
Directors and Advisers<br />
DIRECTORS<br />
Marc Vlessing (Chairman)<br />
Matthew Cooper<br />
David Lambert<br />
all of:<br />
REGISTERED OFFICE<br />
14 Dover Street<br />
London W1S 4LW<br />
SECRETARY<br />
Woodside Secretaries Limited<br />
INVESTMENT MANAGER AND<br />
RECEIVING AGENTS<br />
Octopus Asset Management Limited<br />
14 Dover Street<br />
London W1S 4LW<br />
SPONSOR<br />
Brewin Dolphin Securities Ltd<br />
34 Lisbon Street<br />
Leeds LS1 4LX<br />
SOLICITORS TO THE COMPANY<br />
AND TO THE ISSUE<br />
Brown Rudnick Berlack Israels, LLP<br />
8 Clifford Street<br />
London W1S 2LQ<br />
AUDITORS AND<br />
VCT TAX ADVISER<br />
Grant Thornton UK LLP<br />
1 Westminster Way<br />
Oxford OX2 0PZ<br />
BANKERS<br />
HSBC Bank plc<br />
31 Holborn<br />
London EC1N 2HR<br />
REGISTRARS<br />
Capita Registrars<br />
<strong>The</strong> Registry<br />
34 Beckenham Road<br />
Beckenham<br />
Kent BR3 4TU<br />
15
Definitions<br />
<strong>The</strong> following definitions are used throughout this document, unless the context requires otherwise:<br />
Act<br />
the Companies Act 1985 (as amended)<br />
Admission<br />
admission of the Ordinary Shares to the Official List of the UK<br />
Listing Authority and to trading on the London Stock Exchange's<br />
listed securities market<br />
AIM<br />
the Alternative Investment Market of the London Stock Exchange<br />
annual running costs<br />
the annual costs incurred by the Company in the ordinary course of<br />
its business<br />
Brewin Dolphin Securities or Sponsor<br />
Brewin Dolphin Securities Ltd<br />
BVCA<br />
the British Venture Capital Association<br />
Directors, Board of Directors, Board, “we”or”us”<br />
the directors of the Company whose names appear under Directors<br />
on page 8 of this document<br />
Eclipse VCT<br />
Eclipse VCT plc<br />
Eclipse 2 , Eclipse VCT 2, Fund or Company<br />
Eclipse VCT 2 plc<br />
ICTA<br />
Income and Corporation <strong>Tax</strong>es Act 1988 (as amended)<br />
Income <strong>Tax</strong> Year<br />
the 12 month period over which individuals are assessed to income<br />
tax in the United Kingdom, running from 6 April to the following<br />
5 April<br />
Investment Committee<br />
A committee of individuals drawn from the Investment Manager<br />
Investment Manager, Manager,<br />
Octopus Asset Management or Octopus<br />
Octopus Asset Management Limited<br />
Listing Rules<br />
<strong>The</strong> Listing Rules of the UK Listing Authority<br />
London Stock Exchange<br />
London Stock Exchange plc<br />
net asset value<br />
the aggregate of the gross assets of the Company less its<br />
gross liabilities<br />
OFEX<br />
a market operated by OFEX plc which allows trading of shares in<br />
unquoted companies<br />
Offer<br />
the Offer for subscription of up to 30,000,000 Shares described in<br />
this document<br />
Offer Agreement<br />
the agreement dated 21 December 2004 between the Company, the<br />
Directors, the Investment Manager and Brewin Dolphin Securities<br />
relating to the Offer<br />
Offer Price<br />
100p per Share<br />
Official List<br />
the Official List of the UK Listing Authority<br />
Ordinary Shares or Shares<br />
ordinary shares of 10p each in the capital of the Company<br />
Performance Value<br />
for the relevant financial year end, the sum of (i) the net asset value<br />
of the Fund as at that date, (ii) all distributions declared and/or<br />
paid to Shareholders since Admission and (iii) all performance<br />
related incentive fee payments previously paid to the Investment<br />
Manager, divided by the numbers of Shares in issue<br />
Phoenix VCT<br />
Phoenix VCT plc<br />
Qualifying Company<br />
a company satisfying the conditions of Schedule 28B ICTA as<br />
described in Part 2 of this document<br />
Qualifying Holding<br />
shares in, or securities of, a Qualifying Company, which satisfy the<br />
conditions of Schedule 28B ICTA as described in Part 2 of this<br />
document<br />
Qualifying Investment<br />
an investment in an AIM listed or unquoted company which<br />
satisfies the requirements of Schedule 28B ICTA, as described in<br />
Part 3 of this document<br />
Qualifying Limit<br />
a total amount of £200,000 per individual invested in VCTs in any<br />
one Income <strong>Tax</strong> Year<br />
Qualifying Purchaser<br />
an individual who purchases Shares from an existing Shareholder<br />
and is aged 18 or over and satisfies the conditions of eligibility for<br />
tax relief available to investors in a VCT<br />
Qualifying Subscriber<br />
an individual who subscribes for Shares under the Offer and is aged<br />
18 or over and satisfies the conditions of eligibility for tax relief<br />
available to investors in a VCT<br />
Qualifying Subsidiary<br />
a subsidiary company which falls within the definition of Qualifying<br />
Subsidiary contained in paragraph 10 of Schedule 28B ICTA, as<br />
described in Part 2 of this document<br />
Qualifying Trade<br />
a trade complying with the requirements of Schedule 28B ICTA<br />
Quoted Investments<br />
investments admitted to the Official List of the UK Listing Authority<br />
and admitted to trading on the London Stock Exchange's market for<br />
listed securities or other recognised investment exchange<br />
Shareholders<br />
holders of Ordinary Shares<br />
Team<br />
the Board of Directors of Eclipse VCT 2 and the Investment<br />
Committee<br />
UK Listing Authority<br />
the Financial Services Authority acting in its capacity as the<br />
competent authority for the purposes of Part VI of the Financial<br />
Services and Markets Act 2000<br />
Venture Capital Trust or VCT<br />
a company approved as a venture capital trust under Section<br />
842AA ICTA by the Board of the Inland Revenue<br />
16
Part 2<br />
<strong>Tax</strong>ation Considerations for Investors<br />
<strong>The</strong> following is a general guide to the position of investors. It does not set out any of the legislative provisions in<br />
full and investors should seek their own independent taxation advice.<br />
1 <strong>Tax</strong> Reliefs For Investors<br />
<strong>The</strong> tax reliefs set out below are available to UK residents aged 18 or over who invest in shares in the VCT.<br />
<strong>The</strong>re is no specific limit on the amount an individual can invest in the VCT, but tax reliefs will only be given<br />
to the extent that the total of an individual's subscription or other acquisitions of shares in VCTs in any tax<br />
year does not exceed £200,000. Investors who intend to invest more than £200,000 in VCTs in any one tax<br />
year should take independent advice on this.<br />
2 Income <strong>Tax</strong><br />
a) Relief on subscription<br />
An investor subscribing for shares in the VCT will be entitled to claim income tax relief on amounts<br />
subscribed up to a maximum of £200,000 in any tax year. <strong>The</strong> relief is given at the rate of up to 40% on the<br />
amount subscribed.<br />
b) Dividend relief<br />
An investor who acquires, in any tax year, VCT shares up to a maximum of £200,000 will not be liable to<br />
income tax on dividends paid by the VCT on those shares.<br />
c) Withdrawal of relief<br />
Relief from all or some of income tax on subscription for shares in a VCT is withdrawn if the shares are<br />
disposed of (other than between spouses) within three years of issue or if the VCT loses its approval within<br />
this period.<br />
3 Capital Gains <strong>Tax</strong><br />
a) Relief from capital gains tax on the disposal of shares<br />
Any gains made on shares held within Eclipse 2 are not subject to capital gains tax (subject to a maximum<br />
investment of £200,000 in any one tax year). Similarly, any losses on shares held within Eclipse 2 will not be<br />
treated as an allowable loss. Both of the above apply to the extent that the shares have been acquired within<br />
the limit of £200,000 for any tax year.<br />
b) Purchasers in the market<br />
An individual purchaser of existing shares in the market will be entitled to claim relief from capital gains tax<br />
on disposal (as described in paragraph 3(a) above).<br />
c) Withdrawal of relief<br />
If a VCT which has been granted approval subsequently fails to comply with the conditions for approval, any<br />
gains on the shares after the date on which loss of VCT status takes effect will be taxable. Where VCT status<br />
is treated as never having been given all gains are taxable.<br />
17
4 Obtaining <strong>Tax</strong> Reliefs<br />
a) Income tax relief<br />
(i) <strong>The</strong> VCT will give a certificate to each investor which the investor may use to claim income tax relief,<br />
either by obtaining from the Inland Revenue an adjustment to his tax coding under the PAYE system,<br />
or by waiting until the end of the tax year and using his Self Assessment <strong>Tax</strong> Return to claim relief.<br />
(ii) Dividends received on shares acquired in VCTs up to the qualifying maximum of £200,000 per tax year<br />
need not be shown in the investor's Self Assessment <strong>Tax</strong> Return.<br />
b) Investors not resident in the UK<br />
Investors not resident in the UK should seek their own professional advice as to the consequences of<br />
making an investment in a VCT as they may be subject to tax in other jurisdictions as well as in the UK.<br />
c) VCT reliefs may not be available if the investor takes out a loan specifically to subscribe in the VCT.<br />
5 Consequences of Loss of VCT Status<br />
a) For the VCT<br />
<strong>The</strong> exemption from corporation tax on capital gains will not apply to any gain realised after the time from<br />
which VCT status is lost. Where provisional approval is lost, all gains realised over the period during which<br />
provisional approval was in force will be subject to corporation tax.<br />
b) For Qualifying Subscribers<br />
(i)<br />
Income tax relief on investment<br />
If VCT approval is treated as never having been given, or if it is withdrawn before the shares have been<br />
held for three years, the relief will be withdrawn by the making of an assessment for the year of<br />
assessment for which the relief was originally given on an amount equal to that relief. Interest on<br />
overdue tax may arise.<br />
c) For Qualifying Subscribers and Qualifying Purchasers<br />
(i)<br />
(ii)<br />
Dividend Income<br />
Dividend income will not be exempt from tax in respect of profits or gains arising or accruing in any<br />
accounting period at a time when VCT status has been lost. A notional tax credit equal to 1/9th of the<br />
net dividend paid will be available to offset against income tax due on the dividend.<br />
Capital gains<br />
If provisional VCT approval is withdrawn, approval is treated as never having been given. Gains and<br />
losses on shares in the VCT will be taxable and allowable in the ordinary way. If full VCT approval is<br />
withdrawn, the individual is treated as having disposed of his shares immediately before the status is<br />
lost, for market value at that time, and is treated as reacquiring them at that value immediately after<br />
the status is lost. Thus, any capital gains realised up to that date will be exempt from tax, but gains<br />
after that date will be taxable in the ordinary way.<br />
18
Part 3<br />
Conditions to be met by Venture Capital Trusts<br />
<strong>The</strong> legislation relating to VCTs is contained in ICTA which sets out the tests which a company has to satisfy to obtain<br />
the tax benefits for the VCT and its shareholders. Explanations of these tax benefits and the consequences of<br />
losing VCT status are set out in Part 2. <strong>The</strong>se summaries are not intended to be comprehensive and intending<br />
investors are strongly advised to seek their own independent professional advice.<br />
1 Qualifying as a VCT<br />
(a)<br />
(b)<br />
(c)<br />
(d)<br />
(e)<br />
A VCT must not be a close company and must be approved as a VCT by the Inland Revenue. <strong>The</strong> main<br />
conditions for approval are that throughout its most recent complete accounting period:<br />
the Company's income has been derived wholly or mainly from shares or securities (including loans to<br />
companies with a five year or greater maturity period);<br />
at least 70% by value of its investments are represented by shares or securities in “Qualifying Holdings” (see<br />
below), of which at least 30% by value are represented by holdings of ordinary shares carrying no<br />
preferential rights;<br />
Additionally at least 10% by value of investments in single companies or groups must be in ordinary shares<br />
which carry no preferential rights;<br />
not more than 15% by value of its investments has been held in a single company or group (other than a VCT);<br />
and<br />
it has not retained more than 15% of the income derived in that period from shares and securities.<br />
each class of its ordinary share capital has been quoted on the London Stock Exchange;<br />
Normally, the Inland Revenue cannot give approval of a VCT unless (a) to (e) above have all been met<br />
throughout the Company’s most recent accounting period and the Inland Revenue is satisfied that they will<br />
be met throughout its current accounting period at the time of application for approval. However, to facilitate<br />
the launch of VCTs the Inland Revenue may give provisional approval if it is satisfied that conditions (a), (c),<br />
(d) and (e) will be met throughout the current or subsequent accounting period and condition (b) will be<br />
met in relation to an accounting period commencing no later than three years after the date of the<br />
provisional approval.<br />
2 Qualifying Holdings<br />
Qualifying Holdings comprise new shares or securities (including loans with a five-year or greater maturity<br />
period) issued by unquoted trading companies which exist wholly for the purpose of carrying on one or more<br />
qualifying trades and are limited to investments of up to £1 million per Income <strong>Tax</strong> Year per investee<br />
company. At least 10% of the investment in a qualifying holding must be for eligible ordinary shares and this<br />
minimum percentage must be maintained for qualifying status to be continued. Most trades are qualifying<br />
trades other than certain activities which are regarded as inappropriate. <strong>The</strong> company invested in must not<br />
be controlled by the VCT or any other company and its gross assets must not exceed £15 million<br />
immediately prior to the investment or £16 million thereafter.<br />
Companies whose securities are traded on AIM or OFEX count as unquoted companies for the purposes of<br />
determining Qualifying Holdings. Shares in an unquoted company which subsequently become quoted may<br />
still be regarded as part of a Qualifying Holding for a further five years following quotation. <strong>The</strong> company<br />
must apply the money invested (either directly or via a Qualifying Subsidiary (see below)) for the purpose of<br />
a Qualifying Trade within certain time periods. It must also have no subsidiary companies other than<br />
Qualifying Subsidiaries, and must not itself be controlled by another company.<br />
19
3 Qualifying Trades and Qualifying Subsidiaries<br />
<strong>The</strong> company invested in must exist wholly for the purpose of carrying on one or more Qualifying Trades<br />
and/or be a holding company only of Qualifying Subsidiaries. <strong>The</strong> trade must either be carried on by, or be<br />
intended to be carried on by, the company invested in or by a Qualifying Subsidiary. In the case of a<br />
company intending to carry on a qualifying trade, the qualifying trade must begin within two years of the<br />
issue of shares or securities to a VCT and continue thereafter. <strong>The</strong> trade must be carried on wholly or<br />
mainly in the UK but the company need not be UK resident. Certain trades (for example, dealing in land or<br />
shares or providing financial services) are excluded.<br />
A subsidiary will be a Qualifying Subsidiary if at least 51% of its issued share capital is owned by the<br />
company invested in and certain other tests are also satisfied.<br />
<strong>The</strong> company invested in, or its Qualifying Subsidiary, must spend 80% of the money invested within<br />
12 months.<br />
4 Withdrawal of Approval<br />
Approval of a VCT may be withdrawn if the conditions set out in paragraph 1 above are not met. Withdrawal<br />
of approval generally has effect from the time when notice of withdrawal is given to a VCT.<br />
If approval is withdrawn because the tests have not been met for at least a complete twelve month period,<br />
approval is deemed never to have been given. <strong>The</strong> taxation consequences of approval being deemed never<br />
to have been given are set out in paragraph 5 of Part 2 of this document.<br />
20
Part 4<br />
Terms and Conditions of Application<br />
1. In these terms and conditions, which apply to the Offer, “Applicant” means a person whose name appears<br />
in an Application Form, “Application” means the offer by an Applicant by completing an Application Form and<br />
posting (or delivering) it to Octopus Asset Management Limited, 14 Dover Street, London W1S 4LW (“the<br />
Receiving Agents”) or as otherwise indicated in this document or the Prospectus; and “Prospectus” means<br />
the document dated 4 January 2005 issued in connection with the Offer. Save where the context otherwise<br />
requires, words and expressions defined in this document have the same meanings when used in the<br />
Application Form and explanatory notes in relation thereto.<br />
<strong>The</strong> section headed “Application Procedure” as set out below forms part of these terms and conditions of<br />
Application.<br />
2. <strong>The</strong> contract created by the acceptance of an Application under the Offer will be conditional on:<br />
(i) Admission becoming effective;<br />
(ii) the Offer Agreement between the Company, Octopus and Brewin Dolphin Securities becoming<br />
unconditional in all respects, and not being terminated in accordance with its terms before Admission<br />
becomes effective.<br />
3. <strong>The</strong> right is reserved by the Company to present all cheques and bankers’ drafts for payment on receipt and<br />
to retain share certificates and application monies pending clearance of successful Applicants’ cheques and<br />
bankers’ drafts. <strong>The</strong> Company may treat Applications as valid and binding even if not made in all respects in<br />
accordance with the prescribed instructions and the Company may, at its discretion, accept an Application in<br />
respect of which payment is not received by the Company prior to the closing of the Offer. If any Application<br />
is not accepted in full or if any contract created by acceptance does not become unconditional, the<br />
application monies or, as the case may be, the balance thereof will be returned (without interest) by returning<br />
each relevant Applicant’s cheque or banker’s draft or by crossed cheque in favour of the Applicant, through<br />
the post at the risk of the person(s) entitled thereto. In the meantime, application monies will be retained by<br />
the Receiving Agents in a separate account.<br />
4. By completing and delivering an Application Form, you:<br />
(i) offer to subscribe for the number of Shares specified in your Application Form (or such lesser number<br />
for which your Application is accepted) at the Offer Price on the terms of and subject to this document,<br />
including these terms and conditions, and subject to the Memorandum and Articles of Association of<br />
the Company;<br />
(ii) agree that, in consideration of the Company agreeing that it will not on or prior to the Offer closing<br />
issue or allot any Shares the subject of the Offer to any person other than by means of the procedures<br />
referred to in this document, your Application may not be revoked and that this paragraph shall<br />
constitute a collateral contract between you and the Company which will become binding upon<br />
despatch by post to, or (in the case of delivery by hand) on receipt by, the Receiving Agents of your<br />
Application Form;<br />
(iii) agree and warrant that your cheque or banker’s draft may be presented for payment on receipt and<br />
will be honoured on first presentation and agree that if it is not so honoured you will not be entitled<br />
to receive a certificate in respect of the Ordinary Shares until you make payment in cleared funds for<br />
such Ordinary Shares and such payment is accepted by the Company in its absolute discretion (which<br />
acceptance shall be on the basis that you indemnify it, the Sponsor, and the Receiving Agents against<br />
all costs, damages, losses, expenses and liabilities arising out of or in connection with the failure of<br />
your remittance to be honoured on first presentation) and you agree that, at any time prior to the<br />
unconditional acceptance by the Company of such late payment, the Company may (without<br />
prejudice to its other rights) rescind the agreement to subscribe such Ordinary Shares and may issue<br />
or allot such Ordinary Shares to some other person, in which case you will not be entitled to any<br />
payment in respect of such Ordinary Shares, other than the refund to you, at your risk, of the proceeds<br />
(if any) of the cheque or banker’s draft accompanying your Application, without interest;<br />
21
(iv) agree that, in respect of those Ordinary Shares for which your Application has been received and is<br />
not rejected, your Application may be accepted at the election of the Company either by notification<br />
to the London Stock Exchange of the basis of allocation or by notification of acceptance thereof to the<br />
Receiving Agents;<br />
(v) agree that any monies refundable to you may be retained by the Receiving Agents pending clearance<br />
of your remittance and any verification of identity which is, or which the Company or the Receiving<br />
Agents may consider to be, required for the purposes of the Money Laundering Regulations 2003<br />
and that such monies will not bear interest;<br />
(vi) authorise the Receiving Agents to send share certificate(s) in respect of the number of Ordinary<br />
Shares for which your Application is accepted and/or a crossed cheque for any monies returnable, by<br />
post, without interest, to your address set out in the Application Form and to procure that your name<br />
is placed on the register of members of the Company in respect of such Ordinary Shares;<br />
(vii) agree that all Applications, acceptances of Applications and contracts resulting therefrom shall be<br />
governed in accordance with English law, and that you submit to the jurisdiction of the English courts<br />
and agree that nothing shall limit the right of the Company or the Sponsor to bring any action, suit or<br />
proceeding arising out of or in connection with any such Applications, acceptances of Applications<br />
and contracts in any other manner permitted by law or any court of competent jurisdiction;<br />
(viii) confirm that, in making such Application, you are not relying on any information or representation<br />
in relation to the Company other than the information contained in this document or the Prospectus<br />
and accordingly you agree that no person responsible solely or jointly for this document, the<br />
Prospectus or any part thereof or involved in the preparation thereof shall have any liability for such<br />
information or representation;<br />
(ix) irrevocably authorise the Receiving Agents and/or the Sponsor or any person authorised by either of<br />
them, as your agent, to do all things necessary to effect registration of any Ordinary Shares subscribed<br />
by or issued to you into your name and authorise any representative of the Receiving Agents or of the<br />
Sponsor to execute any document required thereof;<br />
(x) agree that, having had the opportunity to read this document, you shall be deemed to have had notice<br />
of all information and statements concerning the Company and the Shares contained therein;<br />
(xi) confirm that you have reviewed the restrictions contained in paragraph 6 below and warrant that you<br />
are not a “US Person” as defined in the United States Securities Act of 1933 (“Securities Act”) (as<br />
amended), nor a resident of Canada and that you are not applying for any Shares with a view to their<br />
offer, sale or delivery to or for the benefit of any US Person or a resident of Canada;<br />
(xii) declare that you are an individual aged 18 or over;<br />
(xiii) agree that all documents and cheques sent by post to, by or on behalf of the Company or the Receiving<br />
Agents will be sent at the risk of the person entitled thereto;<br />
(xiv) agree, on request by the Company, or the Sponsor on behalf of the Company, to disclose promptly in<br />
writing to the Company, any information which the Company or the Sponsor may reasonably request<br />
in connection with your Application including, without limitation, satisfactory evidence of identity to<br />
ensure compliance with the Money Laundering Regulations 2003 and authorise the Company and the<br />
Sponsor to disclose any information relating to your Application as it considers appropriate;<br />
(xv) agree that the Sponsor will not treat you as its customer by virtue of your Application being accepted<br />
or owe you any duties or responsibilities concerning the price of the Shares or the suitability for you<br />
of Shares or be responsible to you for providing the protections afforded to its customers;<br />
(xvi) where applicable, authorise the Company to make on your behalf any claim to relief from income tax<br />
in respect of any dividends paid by the Company;<br />
(xvii) declare that the Application Form has been completed to the best of your knowledge;<br />
(xviii) undertake that you will notify the Company if you are not or cease to be either a Qualifying Subscriber<br />
or beneficially entitled to the Shares; and<br />
(xix) declare that a loan has not been made to you or any associate, which would not have been made or<br />
not have been made on the same terms, but for you offering to subscribe for, or acquiring, Shares and<br />
that the Shares are being acquired for bona fide commercial purposes and not as part of a scheme or<br />
arrangement the main purpose of which is the avoidance of tax.<br />
22
5. No person receiving a copy of this document, the Prospectus or an Application Form in any territory other<br />
than the UK may treat the same as constituting an invitation or offer to him, nor should he in any event use<br />
such Application Form unless, in the relevant territory, such an invitation or offer could lawfully be made to<br />
him or such Application Form could lawfully be used without contravention of any regulations or other legal<br />
requirements. It is the responsibility of any person outside the UK wishing to make an Application to<br />
satisfy himself as to full observance of the laws of any relevant territory in connection therewith, including<br />
obtaining any requisite governmental or other consents, observing any other formalities requiring to be<br />
observed in such territory and paying any issue, transfer or other taxes required to be paid by such territory.<br />
6. <strong>The</strong> Ordinary Shares have not been and will not be registered under the Securities Act, as amended, and may<br />
not be offered or sold in the United States of America, its territories or possessions or other areas subject to<br />
its jurisdiction (“the USA”). In addition, the Company has not been and will not be registered under the<br />
United States Investment Company Act of 1940, as amended. <strong>The</strong> Investment Manager will not be registered<br />
under the United States Investment Advisers Act of 1940, as amended. No application will be accepted if it<br />
bears an address in the USA.<br />
7. <strong>The</strong> basis of allocation will be determined by the Company in its absolute discretion after consultation with<br />
the Sponsor. <strong>The</strong> right is reserved to reject in whole or in part and scale down and/or ballot any Application<br />
or any part thereof including, without limitation Applications in respect of which any verification of identity<br />
which the Company or the Receiving Agents consider may be required for the purposes of the Money<br />
Laundering Regulations 2003 has not been satisfactorily supplied. Dealings prior to the issue of certificates<br />
for Ordinary Shares will be at the risk of Applicants. A person so dealing must recognise the risk that an<br />
Application may not have been accepted to the extent anticipated or at all.<br />
8. Money Laundering Regulations 2003<br />
Investors should be aware of the following requirements in respect of the above law.<br />
Under the Money Laundering Regulations 2003, we are required to check the identity of clients who invest<br />
over £9,500 or who invest using third party cheques. Octopus Asset Management may therefore undertake<br />
an electronic search for the purposes of verifying your identity. To do so Octopus Asset Management may<br />
check the details you supply against your particulars on any database (public or other) to which we have<br />
access. Octopus Asset Management may also use your details in the future to assist other companies for<br />
verification purposes. A record of this search will be retained. If we cannot verify your identity we may ask<br />
for a recent, original utility bill and an original Inland Revenue <strong>Tax</strong> Notification or a copy of your passport<br />
certified by a bank, solicitor or accountant from you, or a Client Verification Certificate from your IFA. Clients<br />
investing less than £9,500, who invest using cheques drawn off their own bank accounts, will not be subject<br />
to money laundering checks.<br />
Your cheque or bankers’ draft must be drawn in sterling on a account at a branch (which must be in the<br />
United Kingdom, the Channel Islands or the Isle of Man) of a bank which is either a member of the Cheque<br />
and Credit Clearing Company Limited or the CHAPS Clearing Company Limited, a member of the Scottish<br />
Clearing Banks Committee or the Belfast Clearing Committee or which has arranged for its cheques or<br />
bankers’ drafts to be cleared through facilities provided for members of any of those companies or<br />
associations and must bear the appropriate sorting code in the top right hand corner. <strong>The</strong> right is reserved<br />
to reject any Application Form in respect of which the cheque or bankers’ draft has not been cleared on first<br />
presentation. In the event that the offer does not reach its minimum subscription any monies returned will<br />
be sent by cheque crossed “A/C Payee only” in favour of the person named in Section 1 (“the Applicant”).<br />
23
Application procedure<br />
Please send the completed Application Form together with your cheque or bankers draft to<br />
Octopus Asset Management, 14 Dover Street, London, W1S 4LW<br />
If you have any questions on how to complete the Application Form please contact Octopus Asset Management on 0800 619 7979.<br />
Section 1<br />
Please insert your full name, permanent address, daytime telephone number, date of birth and national insurance<br />
number in Section 1. Your national insurance number, which you will find on your pay slip, is required to ensure you obtain<br />
your income tax relief. Joint applications are not permitted but husbands and wives may apply separately.<br />
Section 2<br />
Please note that the choice of investing in either the 2004/05 tax year or the 2005/06 tax year is designed for your tax<br />
planning. Those investors seeking 40% income tax relief for the current tax year should fill in Box A.<br />
Insert in Box A the amount you are investing in the 2004/05 tax year<br />
Insert in Box B the amount you are investing in the 2005/06 tax year.<br />
Insert the sum of Boxes A and B in Box C.<br />
Section 3<br />
Please note that the minimum investment is £3,000. <strong>The</strong> maximum investment, on which tax reliefs on investments in<br />
VCTs are available, is £200,000. Attach your cheque or bankers’ draft to the Application Form for the total amount of your<br />
investment.<br />
Make cheques payable to “ECLIPSE VCT 2 PLC” and crossed “A/C Payee only”. Cheques must be from a recognised UK<br />
bank account and your payment must relate solely to this application. No receipt will be issued.<br />
Read the declaration below and sign and date the Application Form.<br />
If this form is completed and signed by the investor named in Section 1:<br />
By signing this form I HEREBY DECLARE THAT:<br />
(i)<br />
(ii)<br />
(iii)<br />
I have received the Prospectus dated 4 January 2005 and have read the terms and conditions of application<br />
therein and agree to be bound by them;<br />
I will be the beneficial owner of the Shares in ECLIPSE VCT 2 PLC issued to me under this Offer; and<br />
to the best of my knowledge and belief, the personal details I have given to ECLIPSE VCT 2 PLC are correct.<br />
If this form is completed and signed by an authorised financial intermediary or any other person apart from the investor:<br />
By signing this form on behalf of the individual whose details are shown above, I make a declaration (on behalf of such<br />
individual) on the terms of sub-paragraphs (i) to (iii) above.<br />
Section 4<br />
Authorised financial intermediaries who are entitled to receive commission should stamp and complete Section 4, giving<br />
their full name and address, telephone number and details of their authorisation under the Financial Services and Markets<br />
Act 2000. <strong>The</strong> right is reserved to withhold payment of commission if Eclipse VCT 2 PLC is not, in its sole discretion,<br />
satisfied that the authorised financial intermediary is authorised.<br />
Frequently asked questions<br />
Q: Who should I make the cheque payable to?<br />
A: Cheques should be made payable to “Eclipse VCT 2 plc”<br />
Q: Where should I send my application?<br />
A: Your application form and cheque should be sent to Octopus Asset Management, 14 Dover Street,<br />
London, W1S 4LW<br />
Q: What happens after I invest?<br />
A: We will send you confirmation that we have received your application by return of post. You should expect to<br />
receive your share certificate and tax certificate within a few weeks of making your investment.<br />
Please call us at any time concerning your application on 0800 619 7979.
Application Form – Eclipse VCT 2 PLC<br />
Before completing this application form you should read the Terms and Conditions of Application and Application Procedure.<br />
This Offer opens on 5 January 2005 and the closing date will be 30 June 2005 (or earlier if the maximum subscription<br />
has been reached). <strong>The</strong> final closing date will be determined by the Directors in their absolute discretion.<br />
Section 1<br />
Dr/Mr/Mrs/Miss/Other<br />
Forenames<br />
Address<br />
Surname<br />
National Insurance Number<br />
Telephone (Day)<br />
Postcode<br />
Date of Birth<br />
Telephone (Home)<br />
Section 2<br />
I offer to subscribe for the following number of ordinary shares under the Terms and Conditions of the Application as set out<br />
in the Prospectus dated 4 January 2005. <strong>The</strong> Application must be for a minimum of £3,000.<br />
I ENCLOSE A CHEQUE(S) OR BANKERS’ DRAFT(S) DRAWN ON A UK CLEARING BANK, MADE PAYABLE TO “ECLIPSE VCT 2 PLC”.<br />
2004/05 tax year Number of shares At 100p per share £<br />
Box A<br />
2005/06 tax year Number of shares At 100p per share £<br />
Total £<br />
Box B<br />
Box C<br />
Section 3<br />
Signature<br />
Date<br />
Section 4<br />
Financial Adviser: David Knight Telephone 020 - 7318 6323<br />
Mr/Mrs/Miss/Other Forenames Surname<br />
Administrator: Ewoud A. Karelse Telephone 020 - 7318 6339<br />
Mr/Mrs/Miss/Other Forenames Surname<br />
I wish to waive £ 1.5% commission which will be used to satisfy an additional allotment of ordinary shares to the<br />
investor named in Section 1 at no greater cost to the company or the investor.<br />
FSA Number and Company Stamp<br />
<strong>Tax</strong> <strong>Shelter</strong> <strong>Report</strong><br />
Allenbridge Group plc<br />
17 Hill Street<br />
London, W1J 5NZ<br />
FSA: 137716<br />
Investor Service Programme<br />
1. How would you like to be updated ?<br />
❏ Email ❏ Letter<br />
❏ Telephone call from the Fund Manager<br />
2. Would you like to receive invitations to investment<br />
seminars / workshops?<br />
❏ Yes – but only concerning Eclipse VCT 2 plc<br />
❏ Yes to include other Octopus products ❏ No<br />
3. From time to time we may choose to contact you by<br />
telephone to explain an aspect of your investment.<br />
Please indicate below if you are willing for us to call you:<br />
❏ Yes I am happy to be called occasionally<br />
❏ No thank you
Application Form – Eclipse VCT 2 PLC<br />
Before completing this application form you should read the Terms and Conditions of Application and Application Procedure.<br />
This Offer opens on 5 January 2005 and the closing date will be 30 June 2005 (or earlier if the maximum subscription<br />
has been reached). <strong>The</strong> final closing date will be determined by the Directors in their absolute discretion.<br />
Section 1<br />
Dr/Mr/Mrs/Miss/Other<br />
Forenames<br />
Address<br />
Surname<br />
National Insurance Number<br />
Telephone (Day)<br />
Postcode<br />
Date of Birth<br />
Telephone (Home)<br />
Section 2<br />
I offer to subscribe for the following number of ordinary shares under the Terms and Conditions of the Application as set out<br />
in the Prospectus dated 4 January 2005. <strong>The</strong> Application must be for a minimum of £3,000.<br />
I ENCLOSE A CHEQUE(S) OR BANKERS’ DRAFT(S) DRAWN ON A UK CLEARING BANK, MADE PAYABLE TO “ECLIPSE VCT 2 PLC”.<br />
2004/05 tax year Number of shares At 100p per share £<br />
Box A<br />
2005/06 tax year Number of shares At 100p per share £<br />
Total £<br />
Box B<br />
Box C<br />
Section 3<br />
Signature<br />
Date<br />
Section 4<br />
Financial Adviser: David Knight Telephone 020 - 7318 6323<br />
Mr/Mrs/Miss/Other Forenames Surname<br />
Administrator: Ewoud A. Karelse<br />
Telephone<br />
Mr/Mrs/Miss/Other Forenames Surname<br />
020 - 7318 6339<br />
I wish to waive £ 1.5% commission which will be used to satisfy an additional allotment of ordinary shares to the<br />
investor named in Section 1 at no greater cost to the company or the investor.<br />
FSA Number and Company Stamp<br />
<strong>Tax</strong> <strong>Shelter</strong> <strong>Report</strong><br />
Allenbridge Group plc<br />
17 Hill Street<br />
London, W1J 5NZ<br />
FSA: 137716<br />
Investor Service Programme<br />
1. How would you like to be updated ?<br />
❏ Email ❏ Letter<br />
❏ Telephone call from the Fund Manager<br />
2. Would you like to receive invitations to investment<br />
seminars / workshops?<br />
❏ Yes – but only concerning Eclipse VCT 2 plc<br />
❏ Yes to include other Octopus products ❏ No<br />
3. From time to time we may choose to contact you by<br />
telephone to explain an aspect of your investment.<br />
Please indicate below if you are willing for us to call you:<br />
❏ Yes I am happy to be called occasionally<br />
❏ No thank you